Turnover reached RON1.3 billion, up 22.9% from H1/2023. “This increase was mainly the result of growth in almost all of the Group’s business lines, as well as the impact of the acquisitions completed by the Group in 2023 and 2024,” reads the company’s report.
The group registered operating expenses of RON1.23 billion in H1/2024, up 20.8% from H1/2023.
The Group’s operating expenses as a percentage of total operating income represented 94.0% for the 6 months period ended June 30, 2024 and 95.4% for the 6 months period 2023.
On a pro-forma basis, gross sales for 6 months 2024 amount to RON1.31 billion and Adjusted EBITDA to RON199.5 million.
In line with the report, most business lines registered a good performance against the same period of 2023.
Strategic objectives include maintaining medical services at the highest standards, completing ongoing projects such as the expansion of MedLife Medical Park, and inaugurating hospitals in Timișoara and Craiova, expected to be operational by the end of the year.
In terms of new acquisitions and expansion efforts, the company’s representatives confirmed their interest and openness to new development opportunities, both domestically and in neighboring countries. Beyond the intention to consolidate in Hungary, MedLife is also considering testing other markets in the region.
At the same time, the company’s representatives are confident that prudence in acquisitions and mergers will contribute to improving profit margins and gradually reducing the net debt/EBITDA ratio.
MedLife has an almost RON3 billion capitalization, after its shares have gained 45.2% since the start of the year, amid deals worth RON184 million.
(English version by Catalina Apostoiu)